INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $579,567 | +50.7% | 31,262 | -10.1% | 0.02% | +46.7% |
Q2 2023 | $384,483 | -9.6% | 34,767 | +9.7% | 0.02% | -11.8% |
Q1 2023 | $425,442 | +8.1% | 31,682 | -0.4% | 0.02% | -15.0% |
Q4 2022 | $393,440 | -2.4% | 31,806 | +10.1% | 0.02% | -4.8% |
Q3 2022 | $403,000 | +16.1% | 28,890 | +14.8% | 0.02% | +16.7% |
Q2 2022 | $347,000 | -18.2% | 25,160 | -3.4% | 0.02% | 0.0% |
Q1 2022 | $424,000 | +27.3% | 26,033 | +27.2% | 0.02% | +28.6% |
Q4 2021 | $333,000 | +12.5% | 20,468 | +2.6% | 0.01% | -6.7% |
Q3 2021 | $296,000 | +8.4% | 19,953 | +45.8% | 0.02% | +7.1% |
Q2 2021 | $273,000 | +875.0% | 13,686 | +1903.8% | 0.01% | +27.3% |
Q3 2020 | $28,000 | – | 683 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |